134 related articles for article (PubMed ID: 12605660)
1. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
Wood CM; Goodman PA; Vassilev AO; Uckun FM
Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
[TBL] [Abstract][Full Text] [Related]
2. mRNA expression of variant Fas molecules in acute leukemia cells.
Inaba H; Komada Y; Li QS; Zhang XL; Tanaka S; Azuma E; Yamamoto H; Sakurai M
Am J Hematol; 1999 Nov; 62(3):150-8. PubMed ID: 10539881
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.
Zhou M; Gu L; Yeager AM; Findley HW
Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951
[TBL] [Abstract][Full Text] [Related]
4. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
[TBL] [Abstract][Full Text] [Related]
5. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.
Beltinger C; Kurz E; Böhler T; Schrappe M; Ludwig WD; Debatin KM
Blood; 1998 May; 91(10):3943-51. PubMed ID: 9573033
[TBL] [Abstract][Full Text] [Related]
6. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Tamiya S; Etoh K; Suzushima H; Takatsuki K; Matsuoka M
Blood; 1998 May; 91(10):3935-42. PubMed ID: 9573032
[TBL] [Abstract][Full Text] [Related]
7. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL.
Divoky V; Trka JM; Watzinger F; Lion T
Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450
[TBL] [Abstract][Full Text] [Related]
8. A new alternative splice variant of the mouse Fas antigen with a deletion in the N-terminal portion of the extracellular domain.
Nakajima T; Ichii S; Furuyama J; Tamaoki T; Hashimoto T
Life Sci; 1996; 58(9):761-8. PubMed ID: 8632723
[TBL] [Abstract][Full Text] [Related]
9. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines.
Fellenberg J; Mau H; Scheuerpflug C; Ewerbeck V; Debatin KM
Int J Cancer; 1997 Jul; 72(3):536-42. PubMed ID: 9247301
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms.
Tsuruda K; Yamada Y; Hirakata Y; Sugahara K; Maeda T; Atogami S; Tomonaga M; Kamihira S
Leuk Res; 1999 Feb; 23(2):159-66. PubMed ID: 10071131
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.
Liu C; Cheng J; Mountz JD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):957-63. PubMed ID: 7575433
[TBL] [Abstract][Full Text] [Related]
12. Soluble Fas/Apo-1 splicing variants and apoptosis.
Cascino I; Papoff G; Eramo A; Ruberti G
Front Biosci; 1996 Jan; 1():d12-8. PubMed ID: 9159204
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia.
Liu JH; Wei S; Lamy T; Li Y; Epling-Burnette PK; Djeu JY; Loughran TP
Blood; 2002 Aug; 100(4):1449-53. PubMed ID: 12149230
[TBL] [Abstract][Full Text] [Related]
14. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev AO; Mao C; Uckun FM
Leuk Lymphoma; 2003 Jun; 44(6):1011-8. PubMed ID: 12854903
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.
Beltinger C; Böhler T; Karawajew L; Ludwig WD; Schrappe M; Debatin KM
Br J Haematol; 1998 Aug; 102(3):722-8. PubMed ID: 9722299
[TBL] [Abstract][Full Text] [Related]
16. Fas gene mutation in the progression of adult T cell leukemia.
Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
[TBL] [Abstract][Full Text] [Related]
17. Alternatively spliced transcripts of Fas mRNAs in feline lymphoid cells.
Mizuno T; Baba K; Goto Y; Masuda K; Ohno K; Tsujimoto H
Eur J Immunogenet; 2004 Aug; 31(4):159-66. PubMed ID: 15265020
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells.
Chand HS; Ness SA; Kisiel W
Int J Cancer; 2006 Apr; 118(7):1713-20. PubMed ID: 16217771
[TBL] [Abstract][Full Text] [Related]
19. Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity.
Korte A; Möricke A; Beyermann B; Köchling J; Taube T; Kebelmann-Betzing C; Henze G; Seeger K
J Interferon Cytokine Res; 1999 May; 19(5):495-503. PubMed ID: 10386862
[TBL] [Abstract][Full Text] [Related]
20. Lack of Fas (APO-1/CD95) gene structural alterations or transcript variant ratio changes in breast cancer.
Puiu L; Petrakou E; Apostolidou A; Athanassiadou A; Psiouri L; Papachatzopoulou A; Gorgoulis VG; Kotsinas A; Tzoracoeleftherakis E; Maniatis GM; Voutsinas G
Cancer Lett; 2003 May; 194(1):91-7. PubMed ID: 12706862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
